Bệnh sinh học của sự bao bọc xơ trong các ống dẫn lưu glaucoma vùng quanh nhãn cầu

Al-Mobarak F, Khan AO (2009) Two-year survival of Ahmed valve implantation in the first 2 years of life with and without intraoperative mitomycin-C. Ophthalmology 116(10):1862–1865 Ayyala RS, Harman LE, Michelini-Norris B et al (1999) Comparison of different biomaterials for glaucoma drainage devices. Arch Ophthalmol 117(2):233–236 Ayyala RS, Michelini-Norris B, Flores A et al (2000) Comparison of different biomaterials for glaucoma drainage devices: part 2. Arch Ophthalmol 118(8):1081–1084 Ayyala RS, Zurakowski D, Monshizadeh R et al (2002) Comparison of double-plate Molteno and Ahmed glaucoma valve in patients with advanced uncontrolled glaucoma. Ophthalmic Surg Lasers 33(2):94–101 Ayyala RS, Zurakowski D, Smith JA et al (1998) A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology 105(10):1968–1976 Cairns JE (1968) Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol 66(4):673–679 Cantor L, Burgoyne J, Sanders S et al (1998) The effect of mitomycin C on Molteno implant surgery: a 1-year randomized, masked, prospective study. J Glaucoma 7(4):240–246 CAT-152 0102 Trabeculectomy Study Group, Khaw P, Grehn F et al (2007) A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. Ophthalmology 114(10):1822–1830 Choritz L, Koynov K, Renieri G et al (2010) Surface topographies of glaucoma drainage devices and their influence on human tenon fibroblast adhesion. Invest Ophthalmol Vis Sci 51(8):4047–4053 Costa VP, Azuara-Blanco A, Netland PA et al (2004) Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial. Ophthalmology 111(6):1071–1076 Gedde SJ, Herndon LW, Brandt JD et al (2012) Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol 153(5):804–814 Gedde SJ, Schiffman JC, Feuer WJ et al (2012) Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol 153(5):789–803 Hinkle DM, Zurakowski D, Ayyala RS (2007) A comparison of the polypropylene plate Ahmed glaucoma valve to the silicone plate Ahmed glaucoma flexible valve. Eur J Ophthalmol 17(5):696–701 Hong CH, Arosemena A, Zurakowski D, Ayyala RS (2005) Glaucoma drainage devices: a systematic literature review and current controversies. Surv Ophthalmol 50(1):48–60 Ishida K, Netland PA, Costa VP et al (2006) Comparison of polypropylene and silicone Ahmed glaucoma valves. Ophthalmology 113(8):1320–1326 Joshi AB, Parrish RK 2nd, Feuer WF (2005) 2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use. J Glaucoma 14(2):172–174 Jung KI, Lim SA, Park HY, Park CK (2013) Visualization of blebs using anterior-segment optical coherence tomography after glaucoma drainage implant surgery. Ophthalmology 120(5):978–983 Kadri OA, Wilcox MJ (2001) Surface tension controls capsule thickness and collagen orientation in glaucoma shunt devices. Biomed Sci Instrum 37:257–262 Koz OG, Ozhuy S, Tezel GG et al (2007) The effect of paclitaxel on conjunctival wound healing: a pilot study. J Glaucoma 16(7):610–615 Kurnaz E, Kubaloglu A, Yilmaz Y et al (2005) The effect of adjunctive Mitomycin C in Ahmed glaucoma valve implantation. Eur J Ophthalmol 15(1):27–31 Meyer-ter-Vehn T, Grehn F, Schlunck G (2008) Localization of TGF-beta type II receptor and ED-A fibronectin in normal conjunctiva and failed filtering blebs. Mol Vis 14:136–141 Meyer-ter-Vehn T, Han H, Grehn F, Schlunck G (2011) Extracellular matrix elasticity modulates TGF-beta-induced p38 activation and myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci 52(12):9149–9155 Meyer-ter-Vehn T, Katzenberger B, Han H et al (2008) Lovastatin inhibits TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci 49(9):3955–3960 Molteno AC (1969) New implant for drainage in glaucoma. Clinical trial. Br J Ophthalmol 53(9):606–615 Molteno AC, Fucik M, Dempster AG, Bevin TH (2003) Otago Glaucoma Surgery Outcome Study: factors controlling capsule fibrosis around Molteno implants with histopathological correlation. Ophthalmology 110(11):2198–2206 Picht G, Welge-Luessen U, Grehn F, Lutjen-Drecoll E (2001) Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefe’s Arch Clin Exp Ophthalmol 239(3):199–207 Rosbach J, Choritz L, Pfeiffer N, Thieme H (2013) Kapselrevisionen nach Implantation von „Ahmed-Glaucoma-Valve“ Drainageimplantaten. Ophthalmologe Sahiner N, Kravitz DJ, Qadir R et al (2009) Creation of a drug-coated glaucoma drainage device using polymer technology: in vitro and in vivo studies. Arch Ophthalmol 127(4):448–453 Siegner SW, Netland PA, Urban RC Jr et al (1995) Clinical experience with the Baerveldt glaucoma drainage implant. Ophthalmology 102(9):1298–1307 Thieme H, Choritz L, Hofmann-Rummelt C (2011) Histopathologic findings in early encapsulated blebs of young patients treated with the ahmed glaucoma valve. J Glaucoma 20(4):246–251 Tripathi RC, Li J, Chan WF, Tripathi BJ (1994) Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res 59(6):723–727 Wilcox M, Kadri OA (2007) Force and geometry determine structure and function of glaucoma filtration capsules. Ophthalmologica 221(4):238–243